Company news

CorMedix Inc. news in 2021

CorMedix Inc.'s news releases, calls and decks from 2021, newest first.

View company

CorMedix Inc. Reports Third Quarter 2021 Financial Results and Provides Business Update

November 8, 2021

CorMedix Inc. to Report Third Quarter 2021 Financial Results and Provide a Corporate Update on November 9

November 1, 2021

CorMedix Inc. Announces Abstracts at Upcoming Conferences Showing Patient Outcomes and Economic Burden of CRBSI

October 19, 2021

CorMedix Inc. Announces Executive Leadership Changes

October 3, 2021

CorMedix Inc. Announces Regulatory Update

September 6, 2021

CorMedix Inc. Reports Second Quarter and Six Month 2021 Financial Results and Provides Business Update

August 11, 2021

CorMedix Inc. to Report Second Quarter 2021 Financial Results and Provide a Corporate Update on August 12

July 27, 2021

CorMedix Inc. Completes Sale of $1.3 Million of NOL Tax Benefits Through The New Jersey Economic Development Authority Program

June 9, 2021

CorMedix Inc. to Participate in Fireside Chat at the JMP Securities Life Sciences Conference

June 8, 2021

CorMedix Inc. to Present at the Jefferies Virtual Healthcare Conference

May 26, 2021

CorMedix Inc. Reports First Quarter 2021 Financial Results and Provides Business Update

May 12, 2021

CorMedix Inc. Announces Appointment of Chief Commercial Officer

May 12, 2021

CorMedix Inc. to Report First Quarter 2021 Financial Results and Provide a Corporate Update on May 13

May 4, 2021

CorMedix Inc. to Participate at the 7th Annual Truist Securities Life Sciences Summit

April 27, 2021

CorMedix Has Meeting With FDA on DefenCath Catheter Lock Solution NDA

April 13, 2021

CorMedix Inc. to Present at the 20th Annual Needham Virtual Healthcare Conference

April 6, 2021

CorMedix Inc. Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update

March 29, 2021

CorMedix Inc. to Report Fourth Quarter and Fiscal Year 2020 Financial Results and Provide a Corporate Update on March 30

March 22, 2021

CorMedix Approved to Sell $1.3 Million of NOL Tax Benefits Through The New Jersey Economic Development Authority Program

March 14, 2021

CorMedix Inc. Announces Contract Extension of Liz Masson-Hurlburt as Executive Vice President and Head of Clinical Operations

March 10, 2021

CorMedix Inc. to Host Regulatory Update Conference Call

March 7, 2021

CorMedix Receives Complete Response Letter From FDA for DefenCath™ Catheter Lock Solution

February 28, 2021

CorMedix Inc. to Begin Trading on the Nasdaq Stock Exchange

January 20, 2021

Calls in 2021

Decks in 2021